Clinical Trial: Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07729839) titled 'Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection' on May 21.

Brief Summary: A Phase I Study of ADB116 for Injection in Healthy Chinese Adults. This study aims as follows:

Primary Objective:

* To evaluate the safety and tolerability of a single intravenous bolus dose of ADB116 for injection in healthy Chinese adults.

Secondary Objective:

* To evaluate the pharmacokinetic (PK) profile of a single intravenous bolus dose of ADB116 for injection.

Study Start Date: May 31

Study Type: INTERVENTIONAL

Condition: Healthy Adult Participants

Intervention: DRUG: ADB116 for Injection

ADB116 for Injection, si...